Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ: APLS · Real-Time Price · USD

19.97

-2.55 (-11.32%)

At close: Apr 4, 2025, 4:00 PM

21.00

+1.03 (5.16%)

After-hours: Apr 4, 2025, 7:35 PM EDT

Apellis Pharmaceuticals Market Cap

Apellis Pharmaceuticals has a market cap or net worth of $2.51 billion as of April 4, 2025. Its market cap has decreased by -63.48% in one year.

Market Cap

2.51B

Enterprise Value

2.56B

1-Year Change

-63.48%

Ranking

#1667

Market Cap Chart

Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $2.51B, an increase of 262.70%. That is a compound annual growth rate of 19.01%.

Market Cap History

Date	Market Cap	% Change
Apr 3, 2025	2.83B	-28.79%
Dec 31, 2024	3.97B	-44.04%
Dec 29, 2023	7.09B	24.06%
Dec 30, 2022	5.72B	24.22%
Dec 31, 2021	4.60B	6.25%
Dec 31, 2020	4.33B	121.45%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	730.93B
UnitedHealth Group	478.39B
Johnson & Johnson	373.42B
AbbVie	362.22B
Novo Nordisk	307.98B
Abbott Laboratories	228.21B
AstraZeneca	227.81B
Merck & Co.	217.72B

Market Cap Rankings